Advertisement

Cardiovascular Disease Preventive Services Among Smaller Primary Care Practices

Published:December 19, 2021DOI:https://doi.org/10.1016/j.amepre.2021.10.011

      Introduction

      Cardiovascular disease preventive services (aspirin use, blood pressure control, and smoking-cessation support) are crucial to controlling cardiovascular diseases. This study draws from 1,248 small-to-medium-sized primary care practices participating in the EvidenceNOW Initiative from 2015-2016 across 12 states to provide practice-level aspirin use, blood pressure control, and smoking-cessation support estimates; report the percentage of practices that meet Million Hearts targets; and identify the practice characteristics associated with better performance.

      Methods

      This cross-sectional study utilized linear regression modeling (analyzed in 2020–2021) to examine the association of aspirin use, blood pressure control, and smoking-cessation support performance with practice characteristics that included structural attributes (e.g., size, ownership, rurality), practice capacity and contextual characteristics, health information technology, and patient panel demographics.

      Results

      On average, practice performance on aspirin use, blood pressure control, and smoking-cessation support quality measures was 64% for aspirin, 63% for blood pressure, and 62% for smoking-cessation support. The 2012 Million Hearts goal of achieving the rates of 70% was achieved by 52% (aspirin), 32% (blood pressure), and 54% (smoking) of practices. Practice characteristics associated with aspirin use, blood pressure control, and smoking-cessation support performance included ownership (hospital/health system–owned practices had 11% higher aspirin performance than clinician-owned practices [p=0.001]), rurality (rural practices had lower performance than urban practices in all aspirin use, blood pressure control, and smoking-cessation support quality metrics [difference in aspirin=11.1%, p=0.001; blood pressure=4.2%, p=0.022; smoking=14.4%, p=0.009]), and disruptions (practices that experienced >1 major disruption showed lower aspirin performance [−7.1%, p<0.001]).

      Conclusions

      Achieving the Million Hearts targets may be assisted by collecting and reporting practice-level performance, which can promote change at the practice level and identify areas where additional support is needed to achieve initiative goals.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Centers for Disease Control and Prevention (CDC)
        Million hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors–United States, 2011.
        MMWR Morb Mortal Wkly Rep. 2011; 60 (https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6036a4.htm. Accessed May 17, 2020): 1248-1251
        • Bellows BK
        • Ruiz-Negrón N
        • Bibbins-Domingo K
        • et al.
        Clinic-based strategies to reach United States Million Hearts 2022 blood pressure control goals.
        Circ Cardiovasc Qual Outcomes. 2019; 12e005624https://doi.org/10.1161/CIRCOUTCOMES.118.005624
        • Kottke TE
        • Horst S.
        We can save a million hearts.
        Perm J. 2019; 23: 18-289https://doi.org/10.7812/TPP/18-289
      1. About Million Hearts. Million Hearts. https://millionhearts.hhs.gov/about-million-hearts/index.html. Updated November 8, 2020. Accessed November 8, 2020.

        • Arnett DK
        • Blumenthal RS
        • Albert MA
        • et al.
        2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        Circulation. 2019; 140 ([published correction appears in Circulation. 2019;140(11):e649–e650] [published correction appears in Circulation. 2020;141(4):e60] [published correction appears in Circulation. 2020;141(16):e774]): e596-e646https://doi.org/10.1161/CIR.0000000000000678
        • Babb S
        • Malarcher A
        • Schauer G
        • Asman K
        • Jamal A.
        Quitting smoking among adults - United States, 2000-2015.
        MMWR Morb Mortal Wkly Rep. 2017; 65: 1457-1464https://doi.org/10.15585/mmwr.mm6552a1
        • Bailey SR
        • Stevens VJ
        • Fortmann SP
        • et al.
        Long-term outcomes from repeated smoking cessation assistance in routine primary care.
        Am J Health Promot. 2018; 32: 1582-1590https://doi.org/10.1177/0890117118761886
        • Billups SJ
        • Saseen JJ
        • Vande Griend JP
        • Schilling LM
        Blood pressure control rates measured in specialty vs primary care practices within a large integrated health system.
        J Clin Hypertens (Greenwich). 2018; 20: 1253-1259https://doi.org/10.1111/jch.13345
        • Curfman G
        • Bauchner H
        • Greenland P.
        Treatment and control of hypertension in 2020: the need for substantial improvement.
        JAMA. 2020; 324: 1166-1167https://doi.org/10.1001/jama.2020.13322
        • Muntner P
        • Hardy ST
        • Fine LJ
        • et al.
        Trends in blood pressure control among U.S. adults with hypertension, 1999-2000 to 2017-2018.
        JAMA. 2020; 324: 1190-1200https://doi.org/10.1001/jama.2020.14545
        • Williams RJ
        • Masica AL
        • McBurnie MA
        • et al.
        Documentation of the 5 As for smoking cessation by PCPs across distinct health systems.
        Am J Manag Care. 2014; 20 (https://www.ajmc.com/view/documentation-of-the-5-as-for-smoking-cessation-by-pcps-across-distinct-health-systems. Accessed June 1, 2020): e35-e42
        • Mahtta D
        • Ramsey DJ
        • Al Rifai M
        • et al.
        Evaluation of aspirin and statin therapy use and adherence in patients with premature atherosclerotic cardiovascular disease.
        JAMA Netw Open. 2020; 3e2011051https://doi.org/10.1001/jamanetworkopen.2020.11051
        • Cohen DJ
        • Dorr DA
        • Knierim K
        • et al.
        Primary care practices’ abilities and challenges in using electronic health record data for quality improvement.
        Health Aff (Millwood). 2018; 37: 635-643https://doi.org/10.1377/hlthaff.2017.1254
        • Knierim KE
        • Hall TL
        • Dickinson LM
        • et al.
        Primary care practices’ ability to report electronic clinical quality measures in the EvidenceNOW Southwest Initiative to Improve Heart Health.
        JAMA Netw Open. 2019; 2e198569https://doi.org/10.1001/jamanetworkopen.2019.8569
        • Fagnan LJ
        • Ramsey K
        • Dickinson C
        • Kline T
        • Parchman ML.
        Place matters: closing the gap on rural primary care quality improvement capacity-the Healthy Hearts Northwest Study.
        J Am Board Fam Med. 2021; 34: 753-761https://doi.org/10.3122/jabfm.2021.04.210011
        • Cohen DJ
        • Balasubramanian BA
        • Gordon L
        • et al.
        A national evaluation of a dissemination and implementation initiative to enhance primary care practice capacity and improve cardiovascular disease care: the ESCALATES study protocol.
        Implement Sci. 2016; 11: 86https://doi.org/10.1186/s13012-016-0449-8
        • Solberg LI
        • Asche SE
        • Margolis KL
        • Whitebird RR.
        Measuring an organization's ability to manage change: the change process capability questionnaire and its use for improving depression care.
        Am J Med Qual. 2008; 23: 193-200https://doi.org/10.1177/1062860608314942
        • Jaén CR
        • Crabtree BF
        • Palmer RF
        • et al.
        Methods for evaluating practice change toward a patient-centered medical home.
        Ann Fam Med. 2010; 8 ([published correction appears in Ann Fam Med. 2010;8(4):369]): S9-S92https://doi.org/10.1370/afm.1108
        • Nutting PA
        • Crabtree BF
        • Stewart EE
        • et al.
        Effect of facilitation on practice outcomes in the National Demonstration Project model of the patient-centered medical home.
        Ann Fam Med. 2010; 8 ([published correction appears in Ann Fam Med. 2010;8(4):369]): S33-S92https://doi.org/10.1370/afm.1119
        • Rubin DB.
        Multiple Imputation for Nonresponse in Surveys.
        John Wiley & Sons, Hoboken, NJ2004
        • Ritchey MD
        • Wall HK
        • Gillespie C
        • George MG
        • Jamal A
        Division for Heart Disease and Stroke Prevention, CDC. Million hearts: prevalence of leading cardiovascular disease risk factors–United States, 2005-2012.
        MMWR Morb Mortal Wkly Rep. 2014; 63 (https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6321a3.htm. Accessed May 17, 2020): 462-467
        • Levine DM
        • Landon BE
        • Linder JA.
        Quality and experience of outpatient care in the United States for adults with or without primary care.
        JAMA Intern Med. 2019; 179: 363-372https://doi.org/10.1001/jamainternmed.2018.6716
        • Meyer J
        • Arps K
        • Blumenthal R
        • Martin SS.
        New data on aspirin use in the era of more widespread statin use.
        American College of Cardiology, Washington, DC2018 (https://www.acc.org/latest-in-cardiology/articles/2018/09/28/08/08/new-data-on-aspirin-use-in-the-era-of-more-widespread-statin-use. Published September 28, 2018. Accessed March 9, 2021)
        • Berwick DM.
        Continuous improvement as an ideal in health care.
        N Engl J Med. 1989; 320: 53-56https://doi.org/10.1056/NEJM198901053200110
        • Laffel G
        • Blumenthal D.
        The case for using industrial quality management science in health care organizations.
        JAMA. 1989; 262: 2869-2873https://doi.org/10.1001/jama.1989.03430200113036
        • Fung V
        • Schmittdiel JA
        • Fireman B
        • et al.
        Meaningful variation in performance: a systematic literature review.
        Med Care. 2010; 48: 140-148https://doi.org/10.1097/MLR.0b013e3181bd4dc3
        • Selby JV
        • Schmittdiel JA
        • Lee J
        • et al.
        Meaningful variation in performance: what does variation in quality tell us about improving quality?.
        Med Care. 2010; 48: 133-139https://doi.org/10.1097/MLR.0b013e3181c15a6e
        • Solberg LI
        • Crain AL
        • Tillema JO
        • et al.
        Challenges of medical home transformation reported by 118 patient-centered medical home (PCMH) leaders.
        J Am Board Fam Med. 2014; 27: 449-457https://doi.org/10.3122/jabfm.2014.04.130303
        • Solberg LI
        • Stuck LH
        • Crain AL
        • et al.
        Organizational factors and change strategies associated with medical home transformation.
        Am J Med Qual. 2015; 30: 337-344https://doi.org/10.1177/1062860614532307
        • Miller WL
        • Crabtree BF
        • McDaniel R
        • Stange KC.
        Understanding change in primary care practice using complexity theory.
        J Fam Pract. 1998; 46 (https://cdn.mdedge.com/files/s3fs-public/jfp-archived-issues/1998-volume_46-47/JFP_1998-05_v46_i5_understanding-change-in-primary-care-pra.pdf. Accessed March 20, 2020): 369-376
        • Miller WL
        • Crabtree BF
        • Nutting PA
        • Stange KC
        • Jaén CR.
        Primary care practice development: a relationship-centered approach.
        Ann Fam Med. 2010; 8 ([published correction appears in Ann Fam Med. 2010;8(4):369]): S68-S92https://doi.org/10.1370/afm.1089
        • Kottke TE
        • Huebsch JA
        • McGinnis P
        • et al.
        Using principles of complex adaptive systems to implement secondary prevention of coronary heart disease in primary care.
        Perm J. 2016; 20: 17-24https://doi.org/10.7812/TPP/15-100